Viewing StudyNCT00422123



Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00422123
Status: COMPLETED
Last Update Posted: 2009-03-25
First Post: 2007-01-12

Brief Title: Phase 3 Seroquel SR Acute Mania Monotherapy - US
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2007-07
Completion Date Type: ACTUAL
First Submit Date: 2007-01-12
First Submit QC Date: January 12 2007
Study First Post Date: 2007-01-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-03-24
Last Update Post Date: 2009-03-25
Last Update Post Date Type: ESTIMATED